Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Study completedNCT00892749
What this trial is testing

Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Who this might be right for
Chronic Kidney DiseaseRenal DialysisRenal Insufficiency+1 more
Astellas Pharma Inc 248
Large-scale testing (Phase 3)Study completedNCT01017276
What this trial is testing

Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis

Who this might be right for
Chronic Kidney DiseaseRenal DialysisRenal Insufficiency
Astellas Pharma Inc 35
Large-scale testing (Phase 3)Study completedNCT00268957
What this trial is testing

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

Who this might be right for
Kidney DiseasesChronic Renal InsufficiencyEnd-Stage Renal Disease
Genzyme, a Sanofi Company 217
Large-scale testing (Phase 3)Study completedNCT01057407
What this trial is testing

A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Who this might be right for
Chronic Kidney DiseaseRenal DialysisRenal Insufficiency
Astellas Pharma Inc 110
Early research (Phase 1)Study completedNCT02965053
What this trial is testing

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Who this might be right for
Hyperphosphatemia
Chugai Pharmaceutical 26
Large-scale testing (Phase 3)Study completedNCT01069692
What this trial is testing

Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients

Who this might be right for
HyperphosphatemiaChronic Kidney Disease
Novartis 115
Testing effectiveness (Phase 2)Study completedNCT01039428
What this trial is testing

HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Who this might be right for
HyperphosphatemiaChronic Kidney Disease
KDL Inc. 68
Testing effectiveness (Phase 2)Study completedNCT00704483
What this trial is testing

Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis

Who this might be right for
Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy
Novartis Pharmaceuticals 321
Not applicableStudy completedNCT01901107
What this trial is testing

Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

Who this might be right for
Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis
Astellas Pharma Inc 1,078
Testing effectiveness (Phase 2)UnknownNCT00358046
What this trial is testing

Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia

Who this might be right for
Kidney DiseasesRenal Insufficiency
Ilypsa 120
Large-scale testing (Phase 3)Study completedNCT01191255
What this trial is testing

A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis

Who this might be right for
HyperphosphatemiaKidney Failure
Keryx Biopharmaceuticals 441
Testing effectiveness (Phase 2)Study completedNCT00505037
What this trial is testing

ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Who this might be right for
HyperphosphatemiaChronic Kidney Disease
Astellas Pharma Inc 156
Testing effectiveness (Phase 2)Study completedNCT00704678
What this trial is testing

Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis

Who this might be right for
Chronic Kidney Disease
Novartis Pharmaceuticals 203
Testing effectiveness (Phase 2)Study completedNCT02753894
What this trial is testing

Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Who this might be right for
Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Astellas Pharma Inc 73
Large-scale testing (Phase 3)Study completedNCT01514851
What this trial is testing

Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate

Who this might be right for
Hyperphosphatemia
Bayer 259
Large-scale testing (Phase 3)Study completedNCT01578200
What this trial is testing

Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study

Who this might be right for
HemodialysisHyperphosphatemia
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2,309